• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Smart Bandage Monitors and Treats Chronic Wounds

      Smart Bandage Monitors and Treats Chronic Wounds

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Smart Bandage Monitors and Treats Chronic Wounds

      Smart Bandage Monitors and Treats Chronic Wounds

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

    • Nanomedicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Retinitis Pigmentosa Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc

February 15th, 2023 DelveInsight Business Research LLP Releases

The Retinitis Pigmentosa market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Retinitis Pigmentosa pipeline products will significantly revolutionize the Retinitis Pigmentosa market dynamics.  

DelveInsight’s “Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Retinitis Pigmentosa, historical and forecasted epidemiology as well as the Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Retinitis Pigmentosa market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

To Know in detail about the Retinitis Pigmentosa market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Retinitis Pigmentosa Market Insights

Retinitis Pigmentosa Overview

Retinitis Pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Most forms of RP first cause the breakdown of rodcells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness.

Some of the key facts of the Retinitis Pigmentosa Market Report: 

  • The Retinitis Pigmentosa market size was valued at USD 392.42 Million in the year 2020 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The total diagnosed prevalent population of Retinitis Pigmentosa in 7MM was 257,594, in the year 2020
  • The estimates shows that in 2020, the diagnosed prevalence of Retinitis Pigmentosa in the United States was 111,184
  • Among the European 5 countries, Germany had the highest diagnosed prevalent population of RP with 30,809 cases, followed by France, and the United Kingdom
  • Key Retinitis Pigmentosa Companies: SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc, Coave Therapeutics, jCyte, Nightstar Therapeutics, ReNeuron, and others
  • Key Retinitis Pigmentosa Therapies: CTx-PDE6b, jCell, AAV8-RPGR, BIIB112, Human retinal progenitor cells (hrpc) cell, and others
  • The Retinitis Pigmentosa epidemiology based on gender analyzed that a higher percentage of diagnosed prevalence was observed for males, in comparison to females, except Japan, where females occupy a larger patient pool than males

Get a Free sample for the Retinitis Pigmentosa Market Report

Key benefits of the Retinitis Pigmentosa Market report:

  1. Retinitis Pigmentosa market report covers a descriptive overview and comprehensive insight of the Retinitis Pigmentosa Epidemiology and Retinitis Pigmentosa market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Retinitis Pigmentosa market report provides insights on the current and emerging therapies.
  3. Retinitis Pigmentosa market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Retinitis Pigmentosa market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Retinitis Pigmentosa market.

Download the report to understand which factors are driving Retinitis Pigmentosa epidemiology trends @ Retinitis Pigmentosa Epidemiological Insights 

Retinitis Pigmentosa Market  

The dynamics of the Retinitis Pigmentosa market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  

Retinitis Pigmentosa Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Retinitis Pigmentosa Epidemiology Segmentation:

The Retinitis Pigmentosa market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Retinitis Pigmentosa
  • Prevalent Cases of Retinitis Pigmentosa by severity
  • Gender-specific Prevalence of Retinitis Pigmentosa
  • Diagnosed Cases of Episodic and Chronic Retinitis Pigmentosa

Retinitis Pigmentosa Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Retinitis Pigmentosa market or expected to get launched during the study period. The analysis covers Retinitis Pigmentosa market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Retinitis Pigmentosa Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Retinitis Pigmentosa market share @ Retinitis Pigmentosa market forecast 

Retinitis Pigmentosa Therapies and Key Companies

  • CTx-PDE6b: Coave Therapeutics
  • jCell: jCyte
  • AAV8-RPGR/BIIB112: Nightstar Therapeutics (now acquired by Biogen)
  • Human retinal progenitor cells (hrpc) cell: ReNeuron

 Market Drivers

  • Increasing R&D Activities
  • Market share
  • Raising Awareness
  • Novel Curative Therapies

Scope of the Retinitis Pigmentosa Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Retinitis Pigmentosa Companies: SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc, Coave Therapeutics, jCyte, Nightstar Therapeutics, ReNeuron, and others
  • Key Retinitis Pigmentosa Therapies: CTx-PDE6b, jCell, AAV8-RPGR, BIIB112, Human retinal progenitor cells (hrpc) cell, and others
  • Retinitis Pigmentosa Therapeutic Assessment: Retinitis Pigmentosa current marketed and Retinitis Pigmentosa emerging therapies
  • Retinitis Pigmentosa Market Dynamics:  Retinitis Pigmentosa market drivers and Retinitis Pigmentosa market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Retinitis Pigmentosa Unmet Needs, KOL’s views, Analyst’s views, Retinitis Pigmentosa Market Access and Reimbursement 

Retinitis Pigmentosa Market Barriers

  • Lack of awareness about the disease
  • Complex Pathophysiology
  • Lack of Clinically Relevant Biomarker
  • High cost of therapy

Table of Contents 

  1. Retinitis Pigmentosa Market Report Introduction
  2. Executive Summary for Retinitis Pigmentosa
  3. SWOT analysis of Retinitis Pigmentosa
  4. Retinitis Pigmentosa Patient Share (%) Overview at a Glance
  5. Retinitis Pigmentosa Market Overview at a Glance
  6. Retinitis Pigmentosa Disease Background and Overview
  7. Retinitis Pigmentosa Epidemiology and Patient Population
  8. Country-Specific Patient Population of Retinitis Pigmentosa 
  9. Retinitis Pigmentosa Current Treatment and Medical Practices
  10. Retinitis Pigmentosa Unmet Needs
  11. Retinitis Pigmentosa Emerging Therapies
  12. Retinitis Pigmentosa Market Outlook
  13. Country-Wise Retinitis Pigmentosa Market Analysis (2019–2032)
  14. Retinitis Pigmentosa Market Access and Reimbursement of Therapies
  15. Retinitis Pigmentosa Market Drivers
  16. Retinitis Pigmentosa Market Barriers
  17. Retinitis Pigmentosa Appendix
  18. Retinitis Pigmentosa Report Methodology
  19. DelveInsight Capabilities
  20. Disclaimer
  21. About DelveInsight

To know more about Retinitis Pigmentosa treatment, visit @ Retinitis Pigmentosa Medications

Related Reports: 

Retinitis Pigmentosa Pipeline  

“Retinitis Pigmentosa Pipeline Insight, 2023″ report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Retinitis Pigmentosa market. A detailed picture of the Retinitis Pigmentosa pipeline landscape is provided, which includes the disease overview and Retinitis Pigmentosa treatment guidelines. 

Retinitis Pigmentosa Epidemiology 

DelveInsight’s ‘Retinitis Pigmentosa Epidemiology Forecast to 2032′ report delivers an in-depth understanding of the disease, historical and forecasted Retinitis Pigmentosa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Related Reports By DelveInsight –

Hypertrophic Scar Market 

DelveInsight’s “Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Lung Fibrosis Market 

DelveInsight’s “Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Anterior Uveitis Market 

DelveInsight’s “Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

22q11.2 deletion syndrome Market 

DelveInsight’s “22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

X-Linked Retinitis Pigmentosa (XLRP) Market

DelveInsight’s “X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Latest Reports By DelveInsight

Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market

Recent Blog’s By DelveInsight:

  • Insights Into The Cutaneous T-cell Lymphoma Treatment Market
  • Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
  • Emerging Role of Digital Health in the Field of Oncology
  • How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
  • How are Technological Trends and Innovations Reshaping the Dementia Care
  • Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
  • Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
  • Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
  • Evaluating the Key Trends and Technologies Shaping the Future of Dentistry

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact 

Company Name: DelveInsight Business Research LLP

Contact Person: Gaurav Bora

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com/consulting 

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email